Navidea Biopharmaceuticals EBITDA 2010-2023 | NAVB
Navidea Biopharmaceuticals ebitda from 2010 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Navidea Biopharmaceuticals Annual EBITDA (Millions of US $) |
|
|---|---|
| 2022 | $-14 |
| 2021 | $-12 |
| 2020 | $-11 |
| 2019 | $-11 |
| 2018 | $-11 |
| 2017 | $-14 |
| 2016 | $-10 |
| 2015 | $-17 |
| 2014 | $-26 |
| 2013 | $-37 |
| 2012 | $-27 |
| 2011 | $-24 |
| 2010 | $-12 |
| 2009 | $-7 |
| Navidea Biopharmaceuticals Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-09-30 | $-2 |
| 2023-06-30 | $-2 |
| 2023-03-31 | $-2 |
| 2022-12-31 | $-3 |
| 2022-09-30 | $-5 |
| 2022-06-30 | $-3 |
| 2022-03-31 | $-3 |
| 2021-12-31 | $-4 |
| 2021-09-30 | $-2 |
| 2021-06-30 | $-3 |
| 2021-03-31 | $-3 |
| 2020-12-31 | $-3 |
| 2020-09-30 | $-3 |
| 2020-06-30 | $-2 |
| 2020-03-31 | $-3 |
| 2019-12-31 | $-3 |
| 2019-09-30 | $-3 |
| 2019-06-30 | $-3 |
| 2019-03-31 | $-2 |
| 2018-12-31 | $-2 |
| 2018-09-30 | $-4 |
| 2018-06-30 | $-2 |
| 2018-03-31 | $-2 |
| 2017-12-31 | $-3 |
| 2017-09-30 | $-2 |
| 2017-06-30 | $-5 |
| 2017-03-31 | $-3 |
| 2016-12-31 | $-3 |
| 2016-09-30 | $-1 |
| 2016-06-30 | $-2 |
| 2016-03-31 | $-4 |
| 2015-12-31 | $-2 |
| 2015-09-30 | $-4 |
| 2015-06-30 | $-4 |
| 2015-03-31 | $-7 |
| 2014-12-31 | $-4 |
| 2014-09-30 | $-5 |
| 2014-06-30 | $-9 |
| 2014-03-31 | $-8 |
| 2013-12-31 | $-13 |
| 2013-09-30 | $-10 |
| 2013-06-30 | $-8 |
| 2013-03-31 | $-7 |
| 2012-12-31 | $-7 |
| 2012-09-30 | $-9 |
| 2012-06-30 | $-5 |
| 2012-03-31 | $-6 |
| 2011-12-31 | $-9 |
| 2011-09-30 | $-6 |
| 2011-06-30 | $-4 |
| 2011-03-31 | $-5 |
| 2010-12-31 | $-3 |
| 2010-09-30 | $-4 |
| 2010-06-30 | $-1 |
| 2010-03-31 | $-2 |
| 2009-12-31 | $1 |
| 2009-09-30 | $0 |
| 2009-06-30 | $-1 |
| 2009-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.000B |
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.656B | 22.34 |
| Intuitive Surgical (ISRG) | United States | $172.162B | 71.36 |
| IDEXX Laboratories (IDXX) | United States | $52.070B | 54.19 |
| Edwards Lifesciences (EW) | United States | $45.946B | 30.45 |
| Alcon (ALC) | Switzerland | $43.262B | 29.24 |
| IQVIA Holdings (IQV) | United States | $32.485B | 18.36 |
| DexCom (DXCM) | United States | $31.745B | 47.62 |
| Mettler-Toledo (MTD) | United States | $27.033B | 32.09 |
| STERIS (STE) | Ireland | $24.185B | 25.74 |
| Waters (WAT) | United States | $17.354B | 23.84 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.707B | 0.00 |
| Hologic (HOLX) | United States | $15.082B | 16.34 |
| Penumbra (PEN) | United States | $9.868B | 72.08 |
| Sysmex ADR (SSMXY) | Japan | $8.529B | 27.10 |
| Masimo (MASI) | United States | $8.359B | 28.13 |
| Globus Medical (GMED) | United States | $8.180B | 18.87 |
| Teleflex (TFX) | United States | $5.333B | 8.61 |
| Glaukos (GKOS) | United States | $5.153B | 0.00 |
| TransMedics (TMDX) | United States | $4.348B | 66.09 |
| Integer Holdings (ITGR) | United States | $3.741B | 18.67 |
| LivaNova (LIVN) | United Kingdom | $2.933B | 16.79 |
| Veracyte (VCYT) | United States | $2.377B | 32.85 |
| Alphatec Holdings (ATEC) | United States | $2.323B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.314B | 0.00 |
| Artivion (AORT) | United States | $2.020B | 101.93 |
| Nihon Kohden (NHNKY) | Japan | $1.911B | 22.82 |
| Elekta AB (EKTAY) | Sweden | $1.825B | 17.07 |
| Integra LifeSciences Holdings (IART) | United States | $1.106B | 6.33 |
| OPKO Health (OPK) | United States | $1.087B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.087B | 0.00 |
| IRadimed (IRMD) | United States | $0.895B | 43.44 |
| Beta Bionics (BBNX) | United States | $0.741B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.731B | 0.00 |
| AxoGen (AXGN) | United States | $0.687B | 0.00 |
| SiBone (SIBN) | United States | $0.667B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.562B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.520B | 9.18 |
| Semler Scientific (SMLR) | United States | $0.501B | 4.02 |
| OrthoPediatrics (KIDS) | United States | $0.481B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.435B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.393B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.379B | 9.63 |
| Delcath Systems (DCTH) | United States | $0.362B | 86.33 |
| AngioDynamics (ANGO) | United States | $0.356B | 0.00 |
| RxSight (RXST) | United States | $0.345B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.328B | 0.00 |
| NeuroPace (NPCE) | United States | $0.283B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.278B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.277B | 19.09 |
| 908 Devices (MASS) | United States | $0.238B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.227B | 0.00 |
| Neuronetics (STIM) | United States | $0.221B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.220B | 0.00 |
| Inogen (INGN) | United States | $0.202B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.190B | 0.00 |
| CVRx (CVRX) | United States | $0.184B | 0.00 |
| Accuray (ARAY) | United States | $0.158B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.156B | 0.00 |
| LENSAR (LNSR) | United States | $0.151B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.141B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.115B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.111B | 0.00 |
| Hyperfine (HYPR) | United States | $0.108B | 0.00 |
| InspireMD (NSPR) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.095B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.081B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.058B | 0.00 |
| Positron (POSC) | United States | $0.057B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.18 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.041B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.27 |